In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 60 for your search:
Cancer Type/Condition:  Lymphoma, AIDS-related
Stage/Subtype:  AIDS-related primary CNS lymphoma
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H0901329, NCT01189409

2.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: Par 06-0045, NCT01313247

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 54 and under
Sponsor: Other
Protocol IDs: 0107M05202, MT2001-02, NCT00176930

4.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0808, NCI-2012-01673, NCT00761618

5.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EA4/031/09, NCT00884364

6.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VORI911, NCT00893555

7.

Phase: Phase III
Type: Behavioral study, Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 176-25/kmo, NCT01035203

8.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT nr: 2009-015336-15, Protocol nr: 29462, NCT01164046

9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 20120673, NCT01237639

10.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: V212-011, CTRI/2012/05/002673, NCT01254630

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000696704, CRUK-KPS-2008-01, EU-21012, EUDRACT-2007-002080-27, ISRCTN-49116945, NCT01316744

12.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GWCA0999, 2009-016529-32, NCT01337089

13.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-053, U01CA121947, CDR0000581078, NCT00598169

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0711003269, NCT00785798

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ARL-GT 2005, NCT00858793

16.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: SP-24513/DX-FLT-002, NCT01065805

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TED10893, U1111-1116-5472, NCT01084252

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 060051, 06-C-0051, NCT00267865

19.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: Other
Protocol IDs: 2005LS048, UMN-0508M72589, UMN-MT2004-24, UMN-2005LS048, NCT00345865

20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: C-012A, NCT00561301

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FDA IND 100712, NCT00611208

22.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 19 to 70
Sponsor: Other
Protocol IDs: McG 0710, NCT00765466

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: 2212.00, NCI-2009-01244, P30CA015704, U19AI096111, P01CA018029, NCT00968630

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 26
Sponsor: Other
Protocol IDs: L 10,321, NYMC 525, NCT01049854

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2010-0284, NCI-2012-01889, NCT01200485
1    
New Search